Skip to content
← Back to this collection

PUBLICATIONS · 28007754

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2016 Dec
First author
Genadieva-Stavrik S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Genadieva-Stavrik S
      type
      Author
    2. name
      Boumendil A
      type
      Author
    3. name
      Dreger P
      type
      Author
    4. name
      Peggs K
      type
      Author
    5. name
      Briones J
      type
      Author
    6. name
      Corradini P
      type
      Author
    7. name
      Bacigalupo A
      type
      Author
    8. name
      Socié G
      type
      Author
    9. name
      Bonifazi F
      type
      Author
    10. name
      Finel H
      type
      Author
    11. name
      Velardi A
      type
      Author
    12. name
      Potter M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Genadieva-Stavrik S
      type
      Author
    2. name
      Boumendil A
      type
      Author
    3. name
      Dreger P
      type
      Author
    4. name
      Peggs K
      type
      Author
    5. name
      Briones J
      type
      Author
    6. name
      Corradini P
      type
      Author
    7. name
      Bacigalupo A
      type
      Author
    8. name
      Socié G
      type
      Author
    9. name
      Bonifazi F
      type
      Author
    10. name
      Finel H
      type
      Author
    11. name
      Velardi A
      type
      Author
    12. name
      Potter M
      type
      Author
    bibliography ids
    1. nci-bib-86c14262ab9df0ee437debd6
    book metadata
    content sha256
    c3a6aa3ed6c0c141fed25f864d5259b1bc133f17680414b924b01c6be5aea01c
    document type
    citation
    dois
    1. 10.1093/annonc/mdw421
    electronic publication date
    display
    2016 Oct 24
    precision
    day
    year
    2016
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28007754
    immutable id
    pubmed:28007754@c3a6aa3ed6c0c141fed25f864d5259b1bc133f17680414b924b01c6be5aea01c
    journal
    abbreviation
    Ann Oncol
    issn electronic
    1569-8041
    issn print
    0923-7534
    issue
    12
    name
    Annals of oncology : official journal of the European Society for Medical Oncology
    nlm unique id
    9007735
    pages
    2251-2257
    volume
    27
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28007754
      provenance
      batch id
      7a1288ac8bb5f9826304
      provider
      NCBI PubMed ESummary
      record sha256
      ed5d3f69630e38d693c2d9c2bee8649026ce4b312ba080dfefa67b7983189c3f
      response sha256
      0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
      retrieved at
      2026-09-09T23:47:23.138359+00:00
      publication date
      display
      2016 Dec
      precision
      month
      year
      2016
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28007754/
      title
      Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

      Preserved source evidence · Not medical advice